Histamine protects bone marrow against cellular damage induced by ionising radiation

International Journal of Radiation Biology

Volumn 86, Issue 4, 2010, Pages 283-290

  Medina, Vanina A ^a,b   Croci, Máximo ^c   Carabajal, Eliana ^a   Bergoc, Rosa M ^a,b   Rivera, Elena S ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^c Instituto de Immunooncologa   (Argentina)

Author keywords

Bone marrow; Histamine; Ionising radiation; Proliferation; Radioprotection

Indexed keywords

HISTAMINE; HISTIDINE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; BONE MARROW APLASIA; BONE MARROW CELL; CELL DAMAGE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; EDEMA; ERYTHROID CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOID CELL; MALE; MEGAKARYOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RAT; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ANIMALS; BONE MARROW; BONE MARROW CELLS; CELL PROLIFERATION; CESIUM ISOTOPES; HISTAMINE; MALE; MEGAKARYOCYTES; MICE; MICE, NUDE; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; WHOLE-BODY IRRADIATION;

MUS; RATTUS;

EID: 77950495644     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553000903564067     Document Type: Article

References (26)

1. Agarwala SS, Hellstrand K, Gehlsen K, Naredi P. 2004. Immunotherapy with histamine and interleukin 2 in malignant melanoma with liver metastasis. Cancer Immunology, Immunotherapy 53:840-841. (Pubitemid 39149912)
2. Barcellos-Hoff MH, Park C, Wright EG. 2005. Radiation and the microenvironment tumorigenesis and therapy. Nature 5:867-874.
3. Betzen SM, Overgaard J. 1997. Clinical manifestations of normal tissue damage. In: Steel GG, editor. Basic clinical radiobiology. 2nd ed. New York: Oxford University Press, Inc. pp 87-97.
4. Ching TL, Haenen GR, Bast A. 1993. Cimetidine and other H2 receptor antagonists as powerful hydroxyl radical scavengers. Chemico-biological Interactions 86:119-127. (Pubitemid 23080140)
5. Duhamel G, Muratore R, Bryon PA, Horschowski N. 1976. Les lesions histologiques de dans l'aplasie medullaires. Resultats d'un protocole commun portant 261 biopses. Nouvelle Revue Française d'Hématologie 21681-21686. (Pubitemid 8352762)
6. Dziegielewski J, Baulch JE, Goetz W, Coleman MC, Spitz DR, Murley JS, Grdina DJ, Morgan WF. 2008. WR-1065, the active metabolite of amifostine, mitigates radiation-induced delayed genomic instability. Free Radical Biology and Medicine 45:1674-1681.
7. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. 1991. Tolerance of normal tissue to therapeutic irradiation. International Journal of Radiation Oncology, Biology, Physics 21:109-122.
8. Endo Y, Nakamura M, Nitta Y, Kumagai K. 1995. Effects of macrophage depletion on the induction of histidine decarboxylase by lipopolysaccharide, interleukin 1 and tumour necrosis factor. British Journal of Pharmacology 114:187-193.
9. Galmarini CM. 2004. Histamine dihydrochloride (subcutaneous) Maxim. Current Opinion in Investigational Drugs 5:1298-1310.
10. Grdina DJ, Murley JS, Kataoka Y. 2002. Radioprotectans: Current status and new directions. Oncology 63:2-10. (Pubitemid 36005577)
11. Hall EJ, Giaccia AJ. 2006a. Clinical response of normal tissues. In: Hall EJ, Giaccia AJ, editors. Radiobiology for radiobiologists. 6th ed. Philadelphia: Lippincott Williams and Wilkins. pp 327- 348.
12. Hall EJ, Giaccia AJ. 2006b. Radioprotectors. In: Hall EJ, Giaccia AJ, editors. Radiobiology for radiobiologists. 6th ed, Philadelphia: Lippincott Williams and Wilkins. pp 129-134.
13. Horvath Z, Pallinger E, Horvath G, Jelinek I, Falus A, Buzas EI. 2006. Histamine H1 and H2 receptors but not H4 receptors are upregulated during bone marrow regeneration. Cellular Immunology 244:110-115. (Pubitemid 46733914)
14. Kelman Z. 1997. PCNA: Structure, functions and interactions. Oncogene 14:629-640. (Pubitemid 27095854)
15. Liu C,Ma XJ, Jiang X, Wilson SJ, Hofstra CL, Blevitt J, Pyati J, Li X, Chai W, Carruthers N, Lovenberg TW. 2001. Cloning and pharmacological characterization of a fourth histamine receptor (H4) expressed in bone marrow. Molecular Pharmacology 59:420-426. (Pubitemid 32179918)
16. Medina V, Cricco G, Nuñez M, Martín G, Mohamad N, Correa-Fiz F, Sanchez-Jimenez F, Bergoc R, Rivera E. 2006. Histamine-mediated signaling processes in human malignant mammary cells. Cancer Biology and Therapy 5:1462-1471. (Pubitemid 46256614)
17. Medina V, Croci M, Mohamad N, Massari N, Garbarino G, Cricco G, Núñez M, Martín G, Crescenti E, Bergoc R, Rivera E. 2007. Mechanisms underlying the radioprotective effect of histamine on small intestine. International Journal of Radiation Biology 83:653-663. (Pubitemid 47345868)
18. Mitchell MS. 2003. Immunotherapy as part of combinations for the treatment of cancer. International Immunopharmacology 3:1051-1059. (Pubitemid 36830850)
19. Mozdarani H. 2003. Radioprotective properties of histamine H2 receptor antagonists: Present and future prospect. Journal of Radiation Research 44:145-149. (Pubitemid 38738742)
20. Nieto LH, Rozman C. 1980. Biopsia medular en la clínica hematológica. Barcelona: Salvat SA.
21. Pó s Z, Hegyesi H, Rivera ES. 2004. Histamine and cell proliferation. In: Falus A, editor. Histamine: Biology and medical aspects, Budapest: Spring Med Publishing. pp 199- 217.
22. Prasad KN. Radiation syndromes and their modifications. 1995. In: Prasad KN, editor. Handbook of radiobiology. 2nd ed. Florida: CRC Press, Inc. pp 123-152.
23. Romero AI, Thoren FB, Aurelius J, Askarieh G, Brune M, Hellstrand K. 2009. Post-consolidation immunotherapy with histamine dihydrochloride and interleukin-2 in AML. Scandinavian Journal of Immunology 70:194-205.
24. Schneider E, Dy M. 2004. Histamine and hematopoiesis. In: Falus A, editor. Histamine: Biology and medical aspects. Budapest: Spring Med Publishing. pp 227-239.
25. Steel GG. 1997. Introduction: The significance of radiobiology for radiotherapy. In: Steel GG, editor. Basic clinical radiobiology. 2nd ed. New York: Oxford University Press, Inc. pp 1-7.
26. Weiss JF, Landauer MR. 2000. Radioprotection by antioxidants. Annals of the New York Academy of Sciences 899:44-60.